Microfluidic nanodevices for drug sensing and screening applications

Area of Science:

• Biomedical Engineering
• Drug Discovery and Development
• Microfluidics Technology

Background:

• Global health challenges like pandemics and an aging population necessitate rapid drug development.
• Traditional drug screening methods face limitations in efficiency and throughput.
• Microfluidics offers miniaturization, low sample consumption, and integration for advanced drug monitoring and screening.

Purpose of the Study:

• To provide a comprehensive review of microfluidics-based drug sensing and screening strategies.
• To discuss the advantages of microfluidic platforms in drug development.
• To highlight detection techniques, critical parameters, applications, challenges, and future perspectives in microfluidic drug screening.

Main Methods:

• Review and synthesis of existing literature on microfluidics in drug screening.
• Analysis of various detection techniques integrated with microfluidic chips.
• Evaluation of the impact of sensing materials and platform geometries on screening performance.

Main Results:

• Microfluidics-based platforms demonstrate significant advantages for high-throughput drug screening.
• Integration with diverse analytical strategies and biomimetic models enhances drug effect prediction.
• Key parameters influencing screening performance and recent applications in therapeutic and illicit drug screening are summarized.

Conclusions:

• Microfluidics represents a promising technology for efficient and sensitive drug screening.
• Further research into microfluidic platforms, sensing materials, and detection methods will significantly advance drug development.
• Addressing current challenges will unlock the full potential of microfluidics in pharmaceutical research.